Nathan Neufeld, DO
Interventional Pain Medicine · Newnan, GANPI 1497993067
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $111,829 of the $170,964 with a category attached, or 65.4%. Medtronic accounts for 76.7% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $51,567 and has fallen 57.3% since, to $22,025 in 2025. Among interventional pain medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 284 payments — averaging $601.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$131K
- Stryker$39K
- Abbott$187
- Averitas Pharma Inc.$140
- SPR Therapeutics, Inc$81
- Vertex$79
- plus $303 from 12 others
What the payments were for
- Consulting fees$37,90022%
- Speaking & faculty fees$111,82965%
- Grants$1510%
- Travel & lodging$13,8368%
- Food & beverage$7,2204%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 220 | $131,187 |
| Stryker | 41 | $38,986 |
| Abbott | 3 | $187 |
| Averitas Pharma Inc. | 2 | $140 |
| SPR Therapeutics, Inc | 2 | $81 |
| Vertex | 2 | $79 |
| GRT US Holding, Inc. | 1 | $60 |
| Merck | 2 | $42 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| Biotronik NRO, Inc. | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Flowonix Medical Incorporated | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Acacia Pharma Inc | 1 | $15 |
| Merit Medical Systems Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$31,392
- OSTEOCOOL RF ABLATION SYSTEM$30,054
- INTELLIS ADAPTIVESTIM$27,679
- KYPHON EXPRESS II KYPHOPAK TRAY$26,144
- AUTOPLEX$13,500
- OPTABLATE$13,400
- AVAFLEX$8,000
- VERTAPLEX$7,600
- PCD$7,464
- SPINEJACK$7,357
- NA$7,000
- MULTIGEN 2$6,800
- SYNCHROMED$3,266
- ADAPTIVESTIM$3,129
- OSTEOCOOL RF ABLATION$1,631
- mild Device Kit$1,018
- IVAS$800
- AUGMENT INJECTABLE$597
- Vanta$399
- INTELLIS$341
How this compares
$170,964 in reported general payments places this provider in the 95th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 25 | $15,153 |
| Oxycodone Hcl | 159 | $5,259 |
| Fentanyl | 25 | $2,830 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 97 | $2,687 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 56 | $1,939 |
| Gabapentin | 106 | $1,383 |
| Pregabalin | 76 | $1,133 |
| Morphine Sulfate ErMorphine Sulfate | 37 | $829 |
| Morphine Sulfate | 13 | $451 |
| Nortriptyline Hcl | 30 | $430 |
| Hydromorphone Hcl | 18 | $375 |
| Cyclobenzaprine Hcl | 34 | $301 |
| Methadone Hcl | 22 | $290 |
| Duloxetine Hcl | 38 | $275 |
| Tizanidine Hcl | 57 | $256 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $22 | $15,15325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 129 interventional pain medicine providers in Georgia.
Other interventional pain medicine in Newnan
- Sushanth BodaNewnan$55K
- Emmanuel GageBrunswick$602K
- Jordan TateJasper$540K
- Christopher BovinetBrunswick$338K
- David RosenfeldCovington$249K
- Ryan BudwanyLawrenceville$123K
- Alexandra MoreiraAtlanta$79K
- Christopher AndrianoStockbridge$41K
- Guensley DelvaWaycross$37K
- Richard EpterAugusta$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.